These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24905374)

  • 21. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
    Shanks KG; Dahn T; Behonick G; Terrell A
    J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bath Salts Abuse Leading to New-Onset Psychosis and Potential for Violence.
    John ME; Thomas-Rozea C; Hahn D
    Clin Schizophr Relat Psychoses; 2017; 11(2):120-124. PubMed ID: 24951715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New synthetic drugs in addictovigilance.
    Chavant F; Boucher A; Le Boisselier R; Deheul S; Debruyne D
    Therapie; 2015; 70(2):167-89. PubMed ID: 25858573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic Cannabinoids and Cathinones: Prevalence and Markets.
    Bretteville-Jensen AL; Tuv SS; Bilgrei OR; Fjeld B; Bachs L
    Forensic Sci Rev; 2013 Mar; 25(1-2):7-26. PubMed ID: 26226848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.
    Schep LJ; Slaughter RJ; Vale JA; Beasley DM; Gee P
    Clin Toxicol (Phila); 2011 Mar; 49(3):131-41. PubMed ID: 21495881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical toxicology of emerging drugs of abuse.
    Peters FT; Martinez-Ramirez JA
    Ther Drug Monit; 2010 Oct; 32(5):532-9. PubMed ID: 20814349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
    Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
    Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic cannabinoids: A review of the clinical implications of a new drug of choice.
    Freund SA; Banning AS
    JAAPA; 2017 Nov; 30(11):1-4. PubMed ID: 29064946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.
    Vandrey R; Johnson MW; Johnson PS; Khalil MA
    Adolesc Psychiatry (Hilversum); 2013 Apr; 3(2):123-134. PubMed ID: 24921061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
    Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
    J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicological findings of synthetic cannabinoids in recreational users.
    Kronstrand R; Roman M; Andersson M; Eklund A
    J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
    Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K
    Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating correlates of synthetic marijuana and Salvia use in light and intermittent smokers and college students in a predominantly Hispanic sample.
    Gutierrez KM; Cooper TV
    Exp Clin Psychopharmacol; 2014 Dec; 22(6):524-9. PubMed ID: 25285845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A bad trip: lawmakers try to stay one step ahead of the chemists manufacturing dangerous synthetic drugs.
    Lawrence A
    State Legis; 2011 Jun; 37(6):28-9. PubMed ID: 21667572
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug Dependence and Cytotoxicity of Law-evading Drugs: Their Identities Explored from Basic Research].
    Funada M
    Yakugaku Zasshi; 2016; 136(1):65-72. PubMed ID: 26725670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic marijuana use and development of catatonia in a 17-year-old male.
    Smith DL; Roberts C
    Minn Med; 2014 May; 97(5):38. PubMed ID: 24941587
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report.
    McIlroy G; Ford L; Khan JM
    BMC Pharmacol Toxicol; 2016 Jan; 17():2. PubMed ID: 26772803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
    Tung CK; Chiang TP; Lam M
    East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.